NO20090166L - Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens - Google Patents
Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demensInfo
- Publication number
- NO20090166L NO20090166L NO20090166A NO20090166A NO20090166L NO 20090166 L NO20090166 L NO 20090166L NO 20090166 A NO20090166 A NO 20090166A NO 20090166 A NO20090166 A NO 20090166A NO 20090166 L NO20090166 L NO 20090166L
- Authority
- NO
- Norway
- Prior art keywords
- neurodegeneration
- dementia
- alzheimer
- disease
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81354906P | 2006-06-14 | 2006-06-14 | |
US86645106P | 2006-11-20 | 2006-11-20 | |
US89698607P | 2007-03-26 | 2007-03-26 | |
PCT/SE2007/000573 WO2007145570A1 (en) | 2006-06-14 | 2007-06-12 | Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20090166L true NO20090166L (no) | 2009-03-12 |
Family
ID=38831994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20090166A NO20090166L (no) | 2006-06-14 | 2009-01-12 | Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens |
Country Status (16)
Country | Link |
---|---|
US (1) | US20070299087A1 (es) |
EP (1) | EP2035425A1 (es) |
JP (1) | JP2009539975A (es) |
KR (1) | KR20090031564A (es) |
AR (1) | AR061371A1 (es) |
AU (1) | AU2007259432A1 (es) |
BR (1) | BRPI0712731A2 (es) |
CA (1) | CA2654403A1 (es) |
CL (1) | CL2007001732A1 (es) |
EC (1) | ECSP088969A (es) |
IL (1) | IL195574A0 (es) |
MX (1) | MX2008015587A (es) |
NO (1) | NO20090166L (es) |
TW (1) | TW200808796A (es) |
UY (1) | UY30411A1 (es) |
WO (1) | WO2007145570A1 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7700603B2 (en) * | 2003-12-15 | 2010-04-20 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7763609B2 (en) * | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7592348B2 (en) | 2003-12-15 | 2009-09-22 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
AR050184A1 (es) * | 2004-07-28 | 2006-10-04 | Schering Corp | Inhibidores macrociclicos de beta-secretasa |
TWI332005B (en) * | 2005-06-14 | 2010-10-21 | Schering Corp | Aspartyl protease inhibitors |
US8722708B2 (en) * | 2005-06-14 | 2014-05-13 | Merck Sharp & Dohme Inc. | Substituted isoindolines as aspartyl protease inhibitors |
TW200815349A (en) | 2006-06-22 | 2008-04-01 | Astrazeneca Ab | New compounds |
CA2672295A1 (en) * | 2006-12-12 | 2008-06-19 | Schering Corporation | Aspartyl protease inhibitors containing a tricyclic ring system |
WO2008073365A1 (en) | 2006-12-12 | 2008-06-19 | Schering Corporation | Aspartyl protease inhibitors |
AU2009239535A1 (en) * | 2008-04-22 | 2009-10-29 | Schering Corporation | Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use |
WO2010056195A1 (en) * | 2008-11-14 | 2010-05-20 | Astrazeneca Ab | New compounds 575 |
US20100125081A1 (en) * | 2008-11-14 | 2010-05-20 | Astrazeneca Ab | New compounds 574 |
TW201020244A (en) | 2008-11-14 | 2010-06-01 | Astrazeneca Ab | New compounds |
KR20110136826A (ko) * | 2009-03-26 | 2011-12-21 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 신규의 인지기능장해 치료제 |
EP2485590B1 (en) | 2009-10-08 | 2015-01-07 | Merck Sharp & Dohme Corp. | Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use |
US8569310B2 (en) | 2009-10-08 | 2013-10-29 | Merck Sharp & Dohme Corp. | Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions and their use |
UA108363C2 (uk) | 2009-10-08 | 2015-04-27 | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
US8563543B2 (en) | 2009-10-08 | 2013-10-22 | Merck Sharp & Dohme Corp. | Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
WO2012138734A1 (en) | 2011-04-07 | 2012-10-11 | Merck Sharp & Dohme Corp. | C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
WO2012138590A1 (en) | 2011-04-07 | 2012-10-11 | Merck Sharp & Dohme Corp. | Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
BR112014004181A2 (pt) | 2011-08-22 | 2017-06-13 | Merck Sharp & Dohme | composto, composição farmacêutica, e, método de tratamento, prevenção, e / ou retardo do início de uma doença ou patologia |
AU2013235422B2 (en) | 2012-03-19 | 2016-12-15 | Buck Institute For Research On Aging | APP specific BACE inhibitors (ASBIs) and uses thereof |
EP2908824B1 (en) | 2012-10-17 | 2018-05-02 | Merck Sharp & Dohme Corp. | Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
WO2014062549A1 (en) | 2012-10-17 | 2014-04-24 | Merck Sharp & Dohme Corp. | Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
EP2956443B1 (en) | 2013-02-12 | 2019-09-25 | Buck Institute For Research On Aging | Hydantoins that modulate bace-mediated app processing |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008503460A (ja) * | 2004-06-16 | 2008-02-07 | ワイス | β−セクレターゼのインヒビターとしてのジフェニルイミダゾピリミジンおよびイミダゾールアミン |
JP2008526966A (ja) * | 2005-01-14 | 2008-07-24 | ワイス | β−セクレターゼの阻害のためのアミノ−イミダゾロン |
-
2007
- 2007-06-04 TW TW096119991A patent/TW200808796A/zh unknown
- 2007-06-11 US US11/761,131 patent/US20070299087A1/en not_active Abandoned
- 2007-06-12 KR KR1020097000708A patent/KR20090031564A/ko not_active Application Discontinuation
- 2007-06-12 BR BRPI0712731-6A patent/BRPI0712731A2/pt not_active Application Discontinuation
- 2007-06-12 MX MX2008015587A patent/MX2008015587A/es not_active Application Discontinuation
- 2007-06-12 WO PCT/SE2007/000573 patent/WO2007145570A1/en active Application Filing
- 2007-06-12 JP JP2009515346A patent/JP2009539975A/ja active Pending
- 2007-06-12 AU AU2007259432A patent/AU2007259432A1/en not_active Abandoned
- 2007-06-12 EP EP07748236A patent/EP2035425A1/en not_active Withdrawn
- 2007-06-12 CA CA002654403A patent/CA2654403A1/en not_active Abandoned
- 2007-06-13 CL CL2007001732A patent/CL2007001732A1/es unknown
- 2007-06-13 AR ARP070102596A patent/AR061371A1/es unknown
- 2007-06-13 UY UY30411A patent/UY30411A1/es not_active Application Discontinuation
-
2008
- 2008-11-27 IL IL195574A patent/IL195574A0/en unknown
- 2008-12-12 EC EC2008008969A patent/ECSP088969A/es unknown
-
2009
- 2009-01-12 NO NO20090166A patent/NO20090166L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR061371A1 (es) | 2008-08-20 |
CL2007001732A1 (es) | 2008-01-25 |
UY30411A1 (es) | 2008-01-31 |
US20070299087A1 (en) | 2007-12-27 |
IL195574A0 (en) | 2009-09-01 |
WO2007145570A9 (en) | 2008-12-11 |
KR20090031564A (ko) | 2009-03-26 |
MX2008015587A (es) | 2009-01-09 |
TW200808796A (en) | 2008-02-16 |
EP2035425A1 (en) | 2009-03-18 |
ECSP088969A (es) | 2009-01-30 |
BRPI0712731A2 (pt) | 2012-10-02 |
WO2007145570A1 (en) | 2007-12-21 |
CA2654403A1 (en) | 2007-12-21 |
JP2009539975A (ja) | 2009-11-19 |
AU2007259432A1 (en) | 2007-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090166L (no) | Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens | |
NO20090755L (no) | Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens | |
NO20090246L (no) | Substituerte isoindoler som bace-inhibitorer og deres anvendelse | |
NO20082673L (no) | Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens | |
NO20082481L (no) | Nye 2-aminoheterosykluser som er nyttige ved behandling av ABETA-relaterte patologier | |
ECSP099755A (es) | Derivados de pirrolopiridina y su uso como inhibidores de bace | |
NO20083197L (no) | Substituert cinnolin-derivater som GABAA-reseptor modulatorer og metode for deres syntese | |
NO20081315L (no) | Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser | |
EA200900136A1 (ru) | Пирролопиримидины для фармацевтических композиций | |
NO20084516L (no) | Terfenylderivater for behandling av alzheimers sykdom | |
WO2008076046A8 (en) | Novel 2-amino-5, 5-diaryl-imidazol-4-ones | |
NO20083918L (no) | Dihydridiazepiner anvendelige som inhibitorer av proteinkinaser | |
NO20082090L (no) | Pyridopyrimidinoninhibitorer av P13K alfa | |
NO20080981L (no) | Nitrocatechol-derivater som COMT-inhibitorer | |
NZ598242A (en) | Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer | |
CY1112429T1 (el) | Υποκατεστημενα παραγωγα σουλφοναμιδιου | |
NO20064659L (no) | Nye kvarterniserte quinuklidin-estere | |
CR20200286A (es) | DERIVADOS DE DIHIDRO-BENZO-OXAZINA Y DIHIDRO-PIRIDO-OXAZINA (Divisional 2014-0294) | |
NO20085323L (no) | Smeltede, tricykliske sulfonamidinhibitorer av gammasekretase | |
NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
NO20083708L (no) | 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer | |
NO20080394L (no) | N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav | |
NO20084301L (no) | Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler | |
MX2007010400A (es) | Nuevas sales de derivados de hexahidrofenantridina sustituida con 6-heterociclilo. | |
NO20060718L (no) | Substituerte tiofoner og deres anvendelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |